Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease
- 31 January 1999
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 155 (1), 31-41
- https://doi.org/10.1006/exnr.1998.6977
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Alzheimer's diseaseNeurology, 1998
- Aging renders the brain vulnerable to amyloid β-protein neurotoxicityNature Medicine, 1998
- Microglia, Scavenger Receptors, and the Pathogenesis of Alzheimer’s DiseaseNeurobiology of Aging, 1998
- The Pathogenesis of Senile PlaquesJournal of Neuropathology and Experimental Neurology, 1997
- Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic miceNature Medicine, 1997
- Menopause Is Associated With a Significant Increase in Blood Monocyte Number and a Relative Decrease in the Expression of Estrogen Receptors in Human Peripheral MonocytesAmerican Journal of Reproductive Immunology, 1995
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.JCI Insight, 1994
- The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytesBiochemical and Biophysical Research Communications, 1992
- Oxygen Radicals and Human DiseaseAnnals of Internal Medicine, 1987
- Characterization of ameboid microglia isolated from developing mammalian brainJournal of Neuroscience, 1986